BSE filing, NSE: TATACHEM. Summary written from the filing by ALFA Finder's alert engine.
Tata Chemicals Ltd: key numbers
- Share price
- ₹601.95
- Market cap
- ₹15,335 Cr
- Revenue (annual)
- ₹14,584 Cr
- Net profit (annual)
- ₹-1,896 Cr
- P/E (TTM)
- -7.1×Sector 34.1×
- Promoter holding
- 37.98%+0.00% QoQ
- FII holding
- 11.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Chemicals Ltd
All →Tata Chemicals Board Meeting Date
Tata Chemicals will hold a board meeting on 7 November 2026 to approve half-year results. Trading window stays closed until 48 hours after publication.
Tata Chemicals Legal & Regulatory
Tata Chemicals provided a Regulation 30 update on its Kenyan subsidiary TCML. The Kenyan High Court ruled it lacks jurisdiction over the dispute with the Mining Ministry, which is now under government technical review.
Tata Chemicals Legal & Regulatory
Tata Chemicals Limited was directed by the Mumbai Centre for International Arbitration to pay ₹1 Crore in a dispute with Allied Silica Limited. This follows a significantly larger ₹908 Crore claim initially filed against the company.
- Value
- ₹1.00 Cr
Tata Chemicals Legal & Regulatory
Tata Chemicals won an arbitration as the MCIA rejected a ₹908 crore claim by Allied Silica Limited. The company is directed to pay only ₹1 crore plus interest.
- Value
- ₹909.0 Cr
Tata Chemicals Debt & Borrowing
Tata Chemicals filed its half-yearly statement of outstanding debt securities for September 30, 2026. Two listed NCDs with ISINs, coupons, and maturities are reported.
Tata Chemicals Legal & Regulatory
Supreme Court restrained the Government of Gujarat from coercive action on Tata Chemicals' Mithapur land rights. The Court issued a notice to the Government for its response.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr